Increase Amantadine to 200-300 mg Daily
For acute blepharospasm-type dystonia that failed to respond to amantadine 100 mg after benztropine caused intolerable anticholinergic side effects, the recommended next step is to increase amantadine to 200 mg daily (100 mg twice daily), with potential escalation to 300 mg daily in divided doses if needed. 1
Rationale for Dose Escalation
The FDA-approved dosing for drug-induced extrapyramidal reactions, including dystonia, is 100 mg twice daily (200 mg/day) 1. Your patient received only 100 mg daily—half the standard therapeutic dose. The FDA labeling explicitly states that "patients whose responses are not optimal with amantadine hydrochloride at 200 mg daily may benefit from an increase up to 300 mg daily in divided doses" 1.
Dosing Algorithm:
- Start: Increase to 100 mg twice daily (200 mg/day total)
- Monitor: Assess response over 1-2 weeks
- If inadequate response: Escalate to 300 mg daily in divided doses (e.g., 100 mg three times daily)
- Maximum: Up to 400 mg daily has been used for Parkinsonism, though 300 mg is the typical ceiling for dystonia 1
Why This Approach Makes Sense
Amantadine has documented efficacy for dystonia 2, including a recent case report specifically demonstrating benefit for blepharospasm in the context of dyskinesia 3. The drug works through mild dopaminergic activity and has significantly fewer anticholinergic side effects than benztropine 2.
The guidelines for antipsychotic-induced dystonia indicate that anticholinergics are first-line 2, but when these cause intolerable side effects (as in your patient), amantadine represents the logical alternative 2. However, adequate dosing is essential—subtherapeutic doses will predictably fail.
Critical Monitoring Points
Watch for CNS Side Effects:
- Nervousness, anxiety, insomnia, difficulty concentrating, lightheadedness 4, 5, 6
- These occur in approximately 5-10% of patients at 200 mg/day 4
- More serious effects (confusion, hallucinations, seizures) are rare but require immediate discontinuation 4, 5, 6
Renal Function Assessment:
Before escalating the dose, check creatinine clearance. Dose adjustments are mandatory for renal impairment 1:
- CrCl 30-50: 200 mg day 1, then 100 mg daily
- CrCl 15-29: 200 mg day 1, then 100 mg every other day
- CrCl <15: 200 mg every 7 days
Alternative Considerations if Amantadine Fails at Optimal Dosing
If the patient fails to respond to amantadine 200-300 mg daily:
Botulinum Toxin Injection
This is the definitive treatment for blepharospasm 7, 8, 9. OnabotulinumtoxinA and incobotulinumtoxinA are equally effective and should be considered 7. This provides targeted relief without systemic anticholinergic burden and is considered first-line therapy specifically for blepharospasm 7, 8, 9.
Other Oral Medications
- Benzodiazepines (e.g., clonazepam): Commonly used for dystonia 9
- Muscle relaxants 9
- Mexiletine: Reported effective for blepharospasm 9
- Methylphenidate: Emerging evidence as add-on therapy 10
Do NOT Use:
- Dopamine antagonists: Risk of worsening or inducing tardive dyskinesia 9
- Beta-blockers or benzodiazepines: These are for akathisia, not dystonia 2
Common Pitfall to Avoid
The most common error is abandoning amantadine after inadequate trial at subtherapeutic doses. Your patient received 100 mg daily when the standard dose is 200 mg daily. This is analogous to declaring an antibiotic ineffective after giving half the recommended dose. Proper dose escalation must occur before concluding treatment failure.
Additionally, ensure the dystonia is truly drug-induced and not tardive dystonia, which would require different management (switching to atypical antipsychotics, tetrabenazine, or botulinum toxin) 2, 11, 12.